AI Analysis AI Analysis of COLL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add COLL to Watchlist?
Some Reasons Why To Add COLL:
  • Excellent financial health (Piotroski 7/9)
  • Attractive free cash flow ratio of 3.1x
  • High gross margin of 60.7%
PDF

Collegium Pharmaceutical stock upgraded from Strong Sell Candidate to Sell Candidate after Wednesday trading session
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 15, 2026 Loss -8.05%

The Collegium Pharmaceutical stock price gained 1.90% on the last trading day (Wednesday, 3rd Jun 2026), rising from $30.48 to $31.06. During the last trading day the stock fluctuated 3.60% from a day low at $30.15 to a day high of $31.24. The price has fallen in 6 of the last 10 days and is down by -7.61% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 52 thousand more shares were traded than the day before. In total, 469 thousand shares were bought and sold for approximately $14.56 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $30.43 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.35% during the next 3 months and, with a 90% probability hold a price between $28.80 and $36.63 at the end of this 3-month period.

COLL Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 1.90%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Collegium Pharmaceutical stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $32.54 and $34.04. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Collegium Pharmaceutical stock

Collegium Pharmaceutical finds support from accumulated volume at $30.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.09 between high and low, or 3.60%. For the last week, the stock has had daily average volatility of 4.03%.

Collegium Pharmaceutical is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (COLL) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Collegium Pharmaceutical to open at $30.82, and during the day (based on 14 day Average True Range), to move between $30.38 and $31.74, which gives a possible trading interval of +/-$1.35 (+/-4.45%) up or down from last closing price. If Collegium Pharmaceutical takes out the full calculated possible swing range there will be an estimated 4.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $30.48 (1.87%) than the resistance at $35.44 (14.10%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Collegium Pharmaceutical stock A Buy?

Collegium Pharmaceutical holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.826 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $30.82 ( 0.789%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

COLL Performance

Trading levels for COLL

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 31.90 2.70%
R2 31.49 1.37%
R1 31.23 0.546%
Price 31.06
S1 30.40 -2.12%
S2 30.14 -2.95%
S3 29.73 -4.28%

Accumulated Volume Support & Resistance Levels

Level Price
R3 36.30 16.87%
R2 35.62 14.68%
R1 35.44 14.10%
Price 31.06
S1 30.48 -1.87%
S2 0 -
S3 0 -

FAQ

What is the symbol for Collegium Pharmaceutical Stock and on which exchange is it traded?
The symbol for Collegium Pharmaceutical is COLL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Collegium Pharmaceutical Stock?
Collegium Pharmaceutical holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Collegium Pharmaceutical Stock?
Collegium Pharmaceutical Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Collegium Pharmaceutical Stock.

What's the current price of Collegium Pharmaceutical Stock?
As of the end of day on the Jun 03, 2026, the price of an Collegium Pharmaceutical (COLL) share was $31.06.

What is the 52-week high and low for Collegium Pharmaceutical Stock?
The 52-week high for Collegium Pharmaceutical Stock is $50.79 and the 52-week low is $29.08.

What is the market capitalization of Collegium Pharmaceutical Stock?
As of the Jun 03, 2026, the market capitalization of Collegium Pharmaceutical is 988.582M.

When is the next earnings date for Collegium Pharmaceutical?
The upcoming earnings date for Collegium Pharmaceutical is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT COLLEGIUM PHARMACEUTICAL
Collegium Pharmaceutical
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE